1. Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes
- Author
-
Liu, Yan, Lin, Haiyan, Jiang, Lin, Shang, Qingsen, Yin, Lei, Lin, Jiandie D., Wu, Wen-Shu, and Rui, Liangyou
- Subjects
Epigenetic inheritance -- Genetic aspects ,Fatty acids -- Genetic aspects ,Fatty acid synthesis -- Genetic aspects ,Type 2 diabetes -- Genetic aspects ,Diabetes therapy ,Insulin resistance -- Genetic aspects ,Fatty liver -- Genetic aspects ,Enzymes -- Genetic aspects ,Insulin -- Genetic aspects ,Health care industry - Abstract
De novo lipogenesis is tightly regulated by insulin and nutritional signals to maintain metabolic homeostasis. Excessive lipogenesis induces lipotoxicity, leading to nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. Genetic lipogenic programs have been extensively investigated, but epigenetic regulation of lipogenesis is poorly understood. Here, we identified Slug as an important epigenetic regulator of lipogenesis. Hepatic Slug levels were markedly upregulated in mice by either feeding or insulin treatment. In primary hepatocytes, insulin stimulation increased Slug expression, stability, and interactions with epigenetic enzyme lysine-specific demethylase-1 (Lsd1). Slug bound to the fatty acid synthase (Fasn) promoter where Slug-associated Lsd1 catalyzed H3K9 demethylation, thereby stimulating Fasn expression and lipogenesis. Ablation of Slug blunted insulin-stimulated lipogenesis. Conversely, overexpression of Slug, but not a Lsd1 binding-defective Slug mutant, stimulated Fasn expression and lipogenesis. Lsd1 inhibitor treatment also blocked Slug-stimulated lipogenesis. Remarkably, hepatocyte-specific deletion of Slug inhibited the hepatic lipogenic program and protected against obesity-associated NAFLD, insulin resistance, and glucose intolerance in mice. Conversely, liver- restricted overexpression of Slug, but not the Lsd1 binding-defective Slug mutant, had the opposite effects. These results unveil an insulin/Slug/Lsd1/H3K9 demethylation lipogenic pathway that promotes NAFLD and type 2 diabetes., Introduction Fatty acids serve both as a crucial metabolic fuel and as a core structure component of cell membranes to support life. Fatty acid synthase (Fasn) deficiency results in embryonic [...]
- Published
- 2020
- Full Text
- View/download PDF